Health & Biotechnology

  • AVIITAM

    START-UP  | Telemedecine

  • ANATOSCOPE

    START-UP I iLab – Customization anatomical model

  • TCPase Inhibitors

    START-UP I Thérapeutic molecules

  • P42

    START-UP I Peptide – Huntington

  • EMOSIS

    START-UP I i Lab – Diagnostic Kit – Hemostasis

  • NOVAGRAY

    START-UP I i Lab – Cancer Treatment – Radiation Therapy

  • TIX001

    AVAILABLE TECHNOLOGY | Prevention of the toxicity of DNA-damaging anti-cancer agents – Chemotherapy and radiotherapy – Improvement of anti-cancer treatment efficacy

  • NANOMEDSYN

    START-UP I i Lab – Lysosomal Disease

  • DEVINNOVA

    START- UP I Patch – Infarction Detection

  • SPIMA

    AVAILABLE TECHNOLOGY | Stapled Peptides – Inflammatory diseases – Oncology

  • MSC 2.0

    AVAILABLE TECHNOLOGY | Myocardial infarction – Human mesenchymal stem cells – Innovative cell therapy

  • PARADEV

    START-UP I Diagnosis – Parasitosis

  • RESIST-430

    AVAILABLE TECHNOLOGY | Bacterial resistance to antibiotics – Gram-negative bacteria – Gamma-peptides

  • ALPHA-CENTAURI

    MARKETED TECHNOLOGY | Innate immunity – Infectious diseases – Cancer

  • TESOVIR

    AVAILABLE TECHNOLOGY | HIV Reservoir – Biomarkers – mAb

  • VACCIN MALADIE DE NEWCASTLE

    AVAILABLE TECHNOLOGY I Vaccine – Farms

  • SPOT-TO-LAB

    START-UP I Diagnosis- Blood

  • AZELEAD

    START-UP I i Lab – Test toxicity

  • CILCARE

    START-UP I Hearing – Pharmacology

  • EDOP

    START-UP I Patient Support – Video

  • EPIDROP

    START-UP I Circulating tumor cells

  • PL-VAC

    AVAILABLE TECHNOLOGY | Leishmanioses – Secretomes – Multi-epitope peptide vaccine

  • EKILIA

    START-UP I Telemedicine Software

  • NATURAL PAD

    START-UP I i Lab – Serious game – Medicine

  • PERSPECTYV

    AVAILABLE TECHNOLOGY | Facioscapulohumeral dystrophy – Personalized treatment –

  • LRAs

    AVAILABLE TECHNOLOGY | HIV – Shock & Kill Strategy – LRAs

  • CAPDCM

    MARKETED TECHNOLOGY | Microfluidics – Chemoattraction – Drug release

  • RESIST-655

    AVAILABLE TECHNOLOGY | Bacterial resistance to antibiotics – Gram-negative bacteria – Heterocyclic compounds

  • TELE-MOUV

    MARKETED TECHNOLOGY I Chronic diseases – Telemedicine

  • LipoSTAR

    AVAILABLE TECHNOLOGY | Lipophenols – Carbonyl and oxidative stresses – MMP-9

  • OMUNIS

    START-UP I i Lab – Tuberculosis Screening

  • DIADX

    START-UP I Oncology – Circulating DNA Analysis

  • DIAG2TEC – MYELODIAG

    START-UP I Oncology – Therapeutic diagnostic tool

  • 3D-CELLS

    AVAILABLE TECHNOLOGY | Sub-micron fiber matrix – Electrospinning – 3D cell culture

  • DOCK 5

    AVAILABLE TECHNOLOGY | Osteolytic diseases – Dock5 – NCE

  • IMIQUALINES

    AVAILABLE TECHNOLOGY | cancer – imiqualines

  • GeniaTer-CMT1A

    MARKETED TECHNOLOGY | Gene therapy – Nontraumatic intraneural injection – CMT1A

  • BIODOL

    START-UP I iLab – Neuropathic pain

  • TARMAK

    AVAILABLE TECHNOLOGY | Therapeutic combination – Synergy effect in pharmacology – Prostate cancer

  • SMICES

    START-UP I FT Seed – Surgery

  • DIVINS

    START-UP I Aneurysms

  • AGV DISCOVERY

    START-UP I Therapies oncology – Drug design

  • NEURINNOV

    START-UP I iLab – FT Seed – Nerve electrostimulation

  • NODIA

    AVAILABLE TECHNOLOGY I Diabete – Inhibitor

  • BIOSCIENCIA

    START-UP I Purification natural proteins
English